Related references
Note: Only part of the references are listed.Early dosing and efficacy of triptans in acute migraine treatment: the TEMPO study
M. Lanteri-Minet et al.
CEPHALALGIA (2012)
Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study
Marco Bartolini et al.
JOURNAL OF HEADACHE AND PAIN (2012)
Treatment of migraine: update on new therapies
Delphine Magis et al.
CURRENT OPINION IN NEUROLOGY (2011)
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine
Lidia Savi et al.
JOURNAL OF HEADACHE AND PAIN (2011)
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine
Marco Bartolini et al.
JOURNAL OF HEADACHE AND PAIN (2011)
Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan
Lidia Savi et al.
JOURNAL OF HEADACHE AND PAIN (2011)
Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan
Gianni Allais et al.
NEUROLOGICAL SCIENCES (2011)
Frovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studies
Pietro Cortelli et al.
NEUROLOGICAL SCIENCES (2011)
Preclinical pharmacological profile of the selective 5-HTIF receptor agonist lasmiditan
David L. Nelson et al.
CEPHALALGIA (2010)
Triptans for the Management of Migraine
Mollie M. Johnston et al.
DRUGS (2010)
Frovatriptan is Effective and Well Tolerated in Korean Migraineurs: A Double-Blind, Randomized, Placebo-Controlled Trial
Heui-Soo Moon et al.
JOURNAL OF CLINICAL NEUROLOGY (2010)
Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study
Vincenzo Tullo et al.
NEUROLOGICAL SCIENCES (2010)
Triptan Therapy in Migraine
Elizabeth Loder
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Treatment choices and patterns in migraine patients with and without a cardiovascular risk profile
E. A. Wammes-van der Heijden et al.
CEPHALALGIA (2009)
Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks
J. L. Brandes et al.
CEPHALALGIA (2009)
Clinical and Economic Comparison of Frovatriptan Versus other Oral Triptans in the Treatment of Acute Migraine in the Real-World Setting
Mario Guidotti et al.
CLINICAL DRUG INVESTIGATION (2009)
EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force
S. Evers et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Examining the Essence of Migraine—Is it the Blood Vessel or the Brain? A Debate
David W. Dodick
HEADACHE (2008)
Migraine prevalence, disease burden, and the need for preventive therapy
R. B. Lipton et al.
NEUROLOGY (2007)
Frovatriptan use in migraineurs with or at high risk of coronary artery disease
AH Elkind et al.
HEADACHE (2004)
Pharmacokinetics of frovatriptan in adolescent migraineurs
AH Elkind et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe
R Cady et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Pharmacologic management of acute attacks of migraine and prevention of migraine headache
V Snow et al.
ANNALS OF INTERNAL MEDICINE (2002)
Triptans (serotonin, 5-HT1B/1D agonists) in migraine:: detailed results and methods of a meta-analysis of 53 trials
MD Ferrari et al.
CEPHALALGIA (2002)
Clinical pharmacokinetics of frovatriptan
P Buchan et al.
HEADACHE (2002)
Frovatriptan: A review of drug-drug interactions
P Buchan et al.
HEADACHE (2002)
Clinical efficacy of frovatriptan:: Placebo-controlled studies
R Ryan et al.
HEADACHE (2002)
Dose range-finding studies with frovatriptan in the acute treatment of migraine
A Rapoport et al.
HEADACHE (2002)
Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan
G Géraud et al.
HEADACHE (2002)
Pharmacology of the selective 5-HT1B/1D agonist frovatriptan
MB Comer
HEADACHE (2002)